Irish medical technology firm Medtronic has agreed to distribute artificial intelligence (AI)-based stroke...
- MiiSkin Q&A: The AI app detecting early signs of melanoma
- New blood test aims for smarter tuberculosis diagnosis
- Infrared light test offers fast, objective arthritis diagnosis
- Start-up develops blood test for chronic pain and suicide risk
- HIV Testing Day: Bringing viral load assessment to primary care
Philips launches HeartStart Intrepid monitor/defibrillator
Royal Philips has introduced the new HeartStart Intrepid monitor/defibrillator to assess and treat patients in medical emergencies across pre-hospital and hospital settings.
US researchers develop skin sensors to wirelessly monitor health
Researchers at Stanford University in the US have developed new sensors that can be adhered to the skin for wireless health monitoring.
FDA clears Voluntis’ Oleena app to manage cancer symptoms
Digital therapeutics firm Voluntis has received US Food and Drug Administration (FDA) clearance to market its digital app, Oleena, enabling cancer patients to self-manage symptoms.
UK researchers trial new device for monitoring dizziness
Researchers at the University of East Anglia (UEA) and the Norfolk and Norwich University Hospital (NNUH) in the UK have completed a clinical trial assessing a dizziness monitoring device.
Researchers develop soft wearable for health monitoring
A research team at Georgia Institute of Technology in the US has created a soft wearable for wireless, long-term monitoring of health in adults, children and babies.
US remote patient monitoring market is in rude health
The RPM industry is expected to increase sharply over the coming years as the Centers for Medicare & Medicaid (CMS) in the US have begun reimbursement of several RPM activities.
Medtronic to offer Viz.ai’s AI stroke detection software in US
Irish medical technology firm Medtronic has agreed to distribute artificial intelligence (AI)-based stroke care solutions provider Viz.ai’s new technology across US centres.
MiiSkin Q&A: The AI app detecting early signs of melanoma
AI-powered skin mapping technology used by clinicians is now available for patients via a smart phone app designed to detect the common warning signs of melanoma. MiiSkin CEO Jon Friis tells Medical Devices how the technology can help keep an eye on your skin.
Read our magazine
Medical Technology is the essential reading material for decision-makers in the medical device industry, bringing you the latest news and analysis in an exciting, interactive format.